Attitudes toward colon cancer gene testing: Factors predicting test uptake

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 4 II, 1999, Pages 345-351

  Codori, Ann Marie ^a,c   Petersen, Gloria M ^a,b   Miglioretti, Diana L ^a   Larkin, Emma K ^b   Bushey, Marijayne T ^b   Young, Candace ^a   Brensinger, Jill D ^b   Johnson, Karen ^a   Bacon, Judith A ^b   Booker, Susan V ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLON CANCER; COLONOSCOPY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADAPTATION, PSYCHOLOGICAL; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0032954044     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollagg, R. J., Godwin, A. R., Ward, D. C., Nordenskjold, M., Fishel, R., Kolodner, R., and Liskay, R. M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature (Lond.), 368: 258-261, 1994.
2. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer (Published erratum in Cell. 77: 167, 1944). Cell, 75: 1027-1038, 1993.
3. Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomaki, P., Sistonen, P., Aaltonen, L. A., Nystrom-Lahti, M., Guan, X-Y., Zhang, J., Meltzer, P. S., Yu, J.-W., Kao, F-T., Chen, D. J., Cerosaletti, K. M., Fournier, R. E. K., Todd, S., Lewis, T., Leach, R. J., Naylor, S. L., Weissenbach, J., Mecklin, J-P., Jarvinen, H., Petersen, G. M., Hamilton, S. R., Green, J., Jass, J., Watson, P., Lynch, H. T., Trent, J. M., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1225, 1993.
4. Nicolaides, N. C., Papadopoulos, N., Liu, B., Wei, Y. F., Carter, K. C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Dunlop, M. G., Hamilton, S. R., Petersen, G. M., de la Chapelle, A., Vogelstein, B., and Kinzler, K. W. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (Lond.), 371: 75-80, 1994.
5. Papadopoulos, N., Nicolaides, N. C., Wei, Y. F., Ruhen, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., Venter, J. C., Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P., Mecklin, J-P., de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutation of a mutL homolog in hereditary colon cancer. Science (Washington DC), 263: 1625-1629, 1994.
6. Aarnio, M., Mecklin, J. P., Aaltonen, L. A., Nystrom-Lahti, M., and Jarvinen, H. J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer, 64: 430-433, 1995.
7. Lynch, H. T., Smyrk, T. C., Watson, P., Lanspa, S. J., Lynch, J. F., Lynch, P. M., Cavalieri, R. J., and Boland, C. R. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology, 104: 1535-1549, 1993.
8. Marra, G., and Boland, C. R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. (Bethesda), 87: 1114, 1995.
9. Vasen, H. F., Mecklin, J. P., Khan, P. M., and Lynch, H. T. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum, 34: 424-425, 1991.
10. Ponz de Leon, M., Sassatelli, R., Sacchetti, C., Zanghieri, G., Scalmati, A., and Roncucci, L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res., 49: 4344-4348, 1989.
11. Mecklin, J. P. Frequency of hereditary colorectal carcinoma. Gastroenterology, 93: 1021-1025, 1987.
12. Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomaki, P., de la Chapelle, A., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med., 2: 169-174, 1996.
13. Rhyu, M. S. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J. Natl. Cancer Inst. (Bethesda). 88: 240-251, 1996.
14. Wijnen, J., Khan, P. M., Vasen, H., Menko, F., van der Klift, H., van den Broek, M., van Leeuwen-Cornelisse, I., Nagengast, F., Meijers-Heijboer, E. J., Lindhout, D., Griffioen, G., Cats, A., Kleibeuker, J., Varesco, L., Bertario, L., Bisgaard, M-L., Mohr, J., Kolodner, R., and Fodde, R. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am. J. Hum. Genet., 58: 300-307, 1996.
15. Burke, W., Petersen, G., Lynch, P., Botkin, J., Daly, M., Garber, J., Kahn, M. J. E., McTiernan, A., Offit, K., Thomson, E., and Varricchio, C., for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. J. Am. Med. Assoc., 277: 915-919, 1997.
16. Lieberman, D. Endoscopic screening for colorectal cancer. Gastroenterol. Clin. N. Am., 26: 71-83, 1997.
17. Lieberman, D. Colonoscopy as a mass screening tool. Eur. J. Gastroenterol. Hepatol., 10: 225-228, 1998.
18. Jarvinen, H. J., Mecklin, J. P., and Sistonen, P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 108: 1405-1411, 1995.
19. Vasen, H. F. A., Nagengast, F. M., and Meera Khan, P. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet. 345: 1183-1184, 1995.
20. Lieberman, D. A., and Smith, F. W. Screening for colon malignancy with colonoscopy. Am. J. Gastroenterol., 86: 946-951, 1991.
21. Lynch, H. T., Smyrk, T., and Lynch, J. F. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int. J Cancer, 69: 38-43, 1996.
22. Vasen, H. F. A., Mecklin, J. P., Watson, P., Utsunomiya, J., Bertario, L., Lynch, P., Svendsen, L. B., Cristofaro, G., Muller, H., Khan, P. M., and Lynch, H. T. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis. Colon Rectum, 36: 1-4, 1993.
23. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardiello, F. M., Sisk, J. E., Van Antwerp, R., Brown-Davis, C., Marciniak, D. A., and Mayer, R. J. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 112: 594-642, 1997.
24. Faivre, J., Arveux, P., Milan, C., Durand, G., Lamour, J., and Bedenne, L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur. J. Cancer Prev., 1: 49-55, 1991.
25. Mant, D., Fuller, A., Northover, J., Astrop, P., Chivers, A., Crockett, A., Clements, S., and Lawrence, M. Patient compliance with colorectal cancer screening in general practice. Br. J. Gen. Pract., 42: 18-20, 1992.
26. Myers, R. E., Balshem, A. M., Wolf, T. A., Ross, E. A., and Millner, L. Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation. Am. J. Pub. Health. 83: 1620-1622, 1993.
27. Myers, R. E., Balshem, A. M., Wolf, T. A., Ross, E. A., and Millner, L. Adherence to continuous screening for colorectal neoplasia. Med. Care, 31: 508-519, 1993.
28. Richardson, J. L., Danley, K., Mondrus, G. T., Deapen, D., and Mack, T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev. Med., 24: 166-170, 1995.
29. Vernon, S. Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst., 89: 1406-1422, 1997.
30. Meichenbaum, D., and Turk, D. C. Facilitating Treatment Adherence. New York: Plenum Press, 1986.
31. Colombo, L., Corti, G., Magri, F., Marocchi, A., Brambilla, P., Crespi, C., Manieri, L., Ghezzi, S., Giannone, D., Merlino, L., and Mocarelli, P. Results of a pilot study of endoscopic screening of first degree relatives of colorectal cancer patients in Italy. J. Epidemiol. Commun. Health, 51: 453-458, 1997.
32. Beck, N. E., Tomlinson, I. P. M., Homfray, T., Hodgson, S. V., Harocopos, C. J., and Bodmer, W. F. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br. J. Surg., 84: 233-237, 1997.
33. Genuardi, M., Anti, M., Capozzi, E., Leonardi, F., Fornasarig, M., Novella, E., Bellacosa, A., Valenti, A., Gasbarrini, G. B., Roncucci, L., Benatti, P., Percesepe, A., Ponz de Leon, M., Coco, C., de Paoli, A., Valentini, M., Boiocchi, M., Neri, G., and Viel, A. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int. J. Cancer, 75: 835-839, 1998.
34. Fuchs, C. S., Giovannucci, E. L., Colditz, G. A., Hunter, D. J., Speizer, F. E., and Willett, W. C. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med., 331: 1669-1674, 1994.
35. Hobbs, P., Smith, A., George, W. D., and Sellwood, R. A. Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J. Epidemiol. Commun. Health. 34: 19-22, 1980.
36. Johns Hopkins Hereditary Colorectal Cancer Registry. Cancer Screening Guidelines for Families with a History of Colon or Rectal Cancer. Baltimore, MD: Johns Hopkins Medicine, 1996.
37. Aday, L. A. Designing and conducting health surveys: a comprehensive guide, Ed. 2. San Francisco: Jossey-Bass Publishers, 1996.
38. Berthier, F., Potel, G., Leconte, P., Touze, M. D., and Baron, D. Comparative study of methods of measuring acute cancer pain intensity in ED. Am. J. Emer. Med., 16: 132-136, 1998.
39. Seymour, R. A. The use of pain scales in assessing the efficacy of analgesics in post-operative dental pain. Eur. J. Clin. Pharmacol., 23: 441-444, 1982.
40. Wilkie, D. J., Lovejoy, N., Dodd, M., and Tesler, M. D. Cancer pain intensity measurement: concurrent validity of three tools: finger dynamometer, pain intensity number scale, visual analogue scale. Hospice J., 6: 1-13, 1990.
41. Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., and Boyce, A. Psychological side effects of breast cancer screening. Health Psychol., 10: 259-267, 1991.
42. Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C., and Engstrom, P. F. Psychological and behavioral implications of abnormal mammograms. Ann. Intern. Med., 114: 657-661, 1991.
43. Codori, A. M., Hanson, R., and Brandt, J. Self-selection in predictive testing for Huntington's disease. Am. J. Med. Genet., 54: 167-173, 1994.
44. Rand McNally TripMaker. Skokie, IL: Rand McNally & Co., 1996.
45. SAS/STAT Software. SAS Manual. Cary, NC: SAS Institute, 1996.
46. Diggle, P. J., Liang, K-Y., and Zeger, S. L. Analysis of Longitudinal Data. New York: Oxford University Press, 1994.
47. Bostick, R. M., Sprafka, J. M., Virnig, B. A., and Potter, J. D. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev. Med., 23: 816-826, 1994.
48. Evans, A. M., Love, R. R., Meyerowitz, B. E., Leventhal, H., and Nerenz, D. R. Factors associated with active participation in a cancer prevention clinic. Prev. Med., 14: 358-371, 1985.
49. Hobbs, P., Smith, A., George, W. D., and Sellwood, R. A. Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J. Epidemiol. Commun. Health, 34: 19-22, 1980.
50. Weinstein, N. D. The precaution adoption process. Health Psychol., 7: 355-386, 1988.
51. Evans, A. M., Love, R. R., Meyerowitz, B. E., Leventhal, H., and Nerenz, D. R. Factors associated with active participation in a cancer prevention clinic. Prev. Med., 14: 358-371, 1985.
52. Friedman, L. C., Webb, J. A., Bruce, S., Weinberg, A. D., and Cooper, H. P. Skin cancer prevention and early detection intentions and behavior. Am. J. Prev. Med., 11: 59-65, 1995.
53. Lloyd, S., Watson, M., Waites, B., Meyer, L., Eeles, R., Ebbs, S., and Tylee, A. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counseling. Br. J. Cancer, 74: 482-487, 1996.
54. McCaul, K. D., Branstetter, A. D., Schroeder, D. M., and Glasgow, R. E. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol., 15: 423-429, 1996.
55. Petersen, G. M., Larkin, E. K., Codori, A. M., Wang, C-Y., Booker, S. V., Bacon, J. A., Giardiello, F. M., and Boyd, P. Attitudes toward colon cancer gene testing: I. Survey of relatives of colon cancer patients. Cancer Epidemiol. Biomark. Prev., 8: 337-344, 1999.
56. Andrykowski, M. A., Munn, R. K., and Studts, J. L. Interest in learning of personal genetic risk for cancer: a general population survey. Prev. Med., 25: 527-536, 1996.
57. Tambor, E. S., Rimer, B. K., and Strigo, T. S. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am. J. Med. Genet., 68: 43-49, 1997.
58. Croyle, R. T., and Lerman, C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev. Med., 22: 284-292, 1993
59. Smith, K. R., and Croyle, R. T. Attitudes toward genetic testing for colon cancer risk. Am. J. Public Health, 85: 1435-1438, 1995.
60. Lerman, C., Daly, M., Masny, A., and Balshem, A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol., 12: 843-850, 1994.
61. Struewing, J. P., Lerman, C., Kase, K. G., Giambarresi, T. R., Tucker, and M. A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol. Biomark. Prev., 4: 169-173, 1995.
62. Valdimarsdottir, H., Brown, K., Peshkin, B., Schultz, C., Jacobsen, P., Holland, J., Schluger, A., Borgen, P., and Offit, K. Psychosocial predictors of interest in genetic testing for breast cancer risk. Proc. Annu. Meet. Am. Soc. Clin. Oncol., 14: A1640, 1995.
63. Codori, A. M., Bacon, J., Krush, A., and Petersen, G. M. Characteristics of acceptors and refusers of predictive genetic testing for familial adenomalous polyposis. Am. J. Hum. Genet., 55 (Suppl.): 808, 1994.
64. Lerman, C., Narod, S., Schulman, K., Hughes. C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., and Lynch, H. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J. Am. Med. Assoc., 275: 1885-1892, 1996.
65. Evans, D. G., Maher, E. R., Macleod, R., Davies, D. R., and Craufurd, D. Uptake of genetic testing for cancer predisposition. J. Med. Genet., 34: 746-748, 1997.
66. Craufurd, D., Dodge, A., Kerzin-Storrar, L., and Harris, R. Uptake of presymptomatic predictive testing for Huntinglon's disease. Lancet. 334: 603-605, 1989.
67. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cloostermans, T., Cassiman, J. J., Demyttenaere, K., Dom, R., Fryns, J. P., and Van den Berghe, H. Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family. Eur. J. Hum. Genet., 5: 351-363, 1997.
68. Jacopini, G. A., D'Amico, R., Frontali, M., and Vivoan, G. Attitudes of persons at risk and their partners toward genetic testing. Birth Defects, 28: 113-117, 1992.
69. Simpson, S. A., Besson, J., Alexander, D., Allan, K., and Johnston, A. W. One hundred requests for predictive testing for Huntington's disease. Clin. Genet., 41: 326-330, 1992.
70. Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., Vegter-van der Vlis, M., Roos, R. A. C., van Ommen, G. J. B., Duivenvoorden, H. J., and Verhag, F. Presymptomatic DNA-testing for Huntington disease. Pretest attitudes and expectations of applicants and their partners in the Dutch program. Am. J. Med. Genet., 48: 10-16, 1993.
71. Wolff, G., and Walter, W. Attitudes of at-risk persons for Huntington's disease toward predictive genetic testing. Birth Defects. 28: 119-126, 1992.